Sobey, C G <br/><br/>
Tumour necrosis factor alpha augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  1992 
 - 813-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholine--pharmacology<br/>Animals<br/>Aorta<br/>Arginine--analogs & derivatives<br/>Endothelium, Vascular--physiology<br/>Humans<br/>Molecular Weight<br/>Neutrophils--drug effects<br/>Nitric Oxide--metabolism<br/>Nitroarginine<br/>Peroxidase--metabolism<br/>Rabbits<br/>Recombinant Proteins--pharmacology<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Vasoconstriction<br/>Vasoconstrictor Agents--metabolism